ERYTHROMYCIN ESTOLATE Drug Patent Profile
✉ Email this page to a colleague
When do Erythromycin Estolate patents expire, and when can generic versions of Erythromycin Estolate launch?
Erythromycin Estolate is a drug marketed by Barr, Ivax Sub Teva Pharms, Watson Labs, Alpharma Us Pharms, Cosette, and Life Labs. and is included in seven NDAs.
The generic ingredient in ERYTHROMYCIN ESTOLATE is erythromycin estolate. There are one hundred and three drug master file entries for this compound. Additional details are available on the erythromycin estolate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ERYTHROMYCIN ESTOLATE?
- What are the global sales for ERYTHROMYCIN ESTOLATE?
- What is Average Wholesale Price for ERYTHROMYCIN ESTOLATE?
Summary for ERYTHROMYCIN ESTOLATE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 59 |
| Patent Applications: | 2,464 |
| DailyMed Link: | ERYTHROMYCIN ESTOLATE at DailyMed |
Medical Subject Heading (MeSH) Categories for ERYTHROMYCIN ESTOLATE
Anatomical Therapeutic Chemical (ATC) Classes for ERYTHROMYCIN ESTOLATE
US Patents and Regulatory Information for ERYTHROMYCIN ESTOLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barr | ERYTHROMYCIN ESTOLATE | erythromycin estolate | CAPSULE;ORAL | 062162-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cosette | ERYTHROMYCIN ESTOLATE | erythromycin estolate | SUSPENSION;ORAL | 062169-001 | Oct 17, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | ERYTHROMYCIN ESTOLATE | erythromycin estolate | CAPSULE;ORAL | 062087-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cosette | ERYTHROMYCIN ESTOLATE | erythromycin estolate | SUSPENSION;ORAL | 062169-002 | Oct 17, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
